IGF1 increased motility of metastatic MDA-MB-231BO breast cancer cells through activation of the IGF1R [36] and a dominant negative mutant of IGF1R decreased adhesion, invasion and metastasis of MDA-MB-435 cells [37]. This evidence concerns the gene IGF1R and breast carcinoma.